Cargando…
Hsp90表达上调与肺癌细胞化疗耐药的相关性研究
BACKGROUND AND OBJECTIVE: Hsp90 is a major molecular chaperone, which overexpression is involved in oncogenesis, development and drug resistance in many human cancers. The aim of this study is to investigate the relationship between the GGA-induced overexpression of Hsp90 and chemoresistance to Cisp...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999893/ https://www.ncbi.nlm.nih.gov/pubmed/21645448 http://dx.doi.org/10.3779/j.issn.1009-3419.2011.06.02 |
_version_ | 1783331545675726848 |
---|---|
collection | PubMed |
description | BACKGROUND AND OBJECTIVE: Hsp90 is a major molecular chaperone, which overexpression is involved in oncogenesis, development and drug resistance in many human cancers. The aim of this study is to investigate the relationship between the GGA-induced overexpression of Hsp90 and chemoresistance to Cisplatin in SPCA-1 and H446 cell line. METHODS: The protein expressions of Hsp90 induced by GGA at different concentrations were analyzed by Immunofluorescence and Western blotting. Cells survival to Cisplatin was determined using the MTT assays. The effect of Hsp90 expression on the drug resistance to Cisplatin in two Cell Lines was analyzed. RESULTS: Compared with the respective control cells, Hsp90 expressions in both experimental cell lines were up-regulated obviously, exhibiting a dose-dependent manner to GGA. MTT assays revealed that the IC(50)s of cisplatin also showed a substantial elevation for the experimental cells of SPCA-1 and H446, and this elevation was also associated with GGA concerntration. CONCLUSION: GGA is effective for the induction of Hsp90 in the SPCA-1 and H446 cell line. Up-regulated Hsp90 is associated with the chemoresistance to Cisplatin in SPCA-1and H446 cells. |
format | Online Article Text |
id | pubmed-5999893 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | 中国肺癌杂志编辑部 |
record_format | MEDLINE/PubMed |
spelling | pubmed-59998932018-07-06 Hsp90表达上调与肺癌细胞化疗耐药的相关性研究 Zhongguo Fei Ai Za Zhi 基础研究 BACKGROUND AND OBJECTIVE: Hsp90 is a major molecular chaperone, which overexpression is involved in oncogenesis, development and drug resistance in many human cancers. The aim of this study is to investigate the relationship between the GGA-induced overexpression of Hsp90 and chemoresistance to Cisplatin in SPCA-1 and H446 cell line. METHODS: The protein expressions of Hsp90 induced by GGA at different concentrations were analyzed by Immunofluorescence and Western blotting. Cells survival to Cisplatin was determined using the MTT assays. The effect of Hsp90 expression on the drug resistance to Cisplatin in two Cell Lines was analyzed. RESULTS: Compared with the respective control cells, Hsp90 expressions in both experimental cell lines were up-regulated obviously, exhibiting a dose-dependent manner to GGA. MTT assays revealed that the IC(50)s of cisplatin also showed a substantial elevation for the experimental cells of SPCA-1 and H446, and this elevation was also associated with GGA concerntration. CONCLUSION: GGA is effective for the induction of Hsp90 in the SPCA-1 and H446 cell line. Up-regulated Hsp90 is associated with the chemoresistance to Cisplatin in SPCA-1and H446 cells. 中国肺癌杂志编辑部 2011-06-20 /pmc/articles/PMC5999893/ /pubmed/21645448 http://dx.doi.org/10.3779/j.issn.1009-3419.2011.06.02 Text en 版权所有©《中国肺癌杂志》编辑部2011 https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) License. See: https://creativecommons.org/licenses/by/3.0/ |
spellingShingle | 基础研究 Hsp90表达上调与肺癌细胞化疗耐药的相关性研究 |
title | Hsp90表达上调与肺癌细胞化疗耐药的相关性研究 |
title_full | Hsp90表达上调与肺癌细胞化疗耐药的相关性研究 |
title_fullStr | Hsp90表达上调与肺癌细胞化疗耐药的相关性研究 |
title_full_unstemmed | Hsp90表达上调与肺癌细胞化疗耐药的相关性研究 |
title_short | Hsp90表达上调与肺癌细胞化疗耐药的相关性研究 |
title_sort | hsp90表达上调与肺癌细胞化疗耐药的相关性研究 |
topic | 基础研究 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999893/ https://www.ncbi.nlm.nih.gov/pubmed/21645448 http://dx.doi.org/10.3779/j.issn.1009-3419.2011.06.02 |
work_keys_str_mv | AT hsp90biǎodáshàngdiàoyǔfèiáixìbāohuàliáonàiyàodexiāngguānxìngyánjiū AT hsp90biǎodáshàngdiàoyǔfèiáixìbāohuàliáonàiyàodexiāngguānxìngyánjiū AT hsp90biǎodáshàngdiàoyǔfèiáixìbāohuàliáonàiyàodexiāngguānxìngyánjiū |